All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-1122-LX906 | Anti-FAP (X11X110) h(ICOS-4-1BB-CD3ζ) CAR, pCDCAR1 | Human | X11X110 | Human | scFv-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0123-ZP487 | Anti-FAP (NI-206.82C2) h(scFv-CD3ε) TRuC, pCDTRC1 | Mouse | NI-206.82C2 | Human | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP748 | Anti-FAP (MO36) h(scFv-CD3ε) TRuC, pCDTRC1 | Human; Mouse | MO36 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0323-ZP142 | Anti-FAP (Sibrotuzumab scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | Sibrotuzumab | Human | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP143 | Anti-FAP (3F2 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | 3F2 | Human | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP144 | Anti-FAP (hu36 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | hu36 | Human | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP485 | Anti-FAP (F5 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Mouse | F5 | Human | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-LX163 | Anti-FAP VHH(X3XH163) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH163 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX164 | Anti-FAP VHH(X3XH164) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH164 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX532 | Anti-FAP VHH(X3XH163) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH163 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX533 | Anti-FAP VHH(X3XH164) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH164 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX901 | Anti-FAP VHH(X3XH163) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH163 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX902 | Anti-FAP VHH(X3XH164) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH164 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX3821 | TRAC-FAP (X3XT23) h(CD28-41BB-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT23 | Mouse | Homology arm-EF1a-scFv-CD28-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX3822 | TRAC-FAP (X3XT24) h(CD28-41BB-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT24 | Mouse | Homology arm-EF1a-scFv-CD28-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX4063 | TRAC-FAP (X3XT23) h(CD28-OX40-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT23 | Mouse | Homology arm-EF1a-scFv-CD28-OX40-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX4064 | TRAC-FAP (X3XT24) h(CD28-OX40-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT24 | Mouse | Homology arm-EF1a-scFv-CD28-OX40-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX4305 | TRAC-FAP (X3XT23) h(ICOS-4-1BB-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT23 | Mouse | Homology arm-EF1a-scFv-ICOS-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX4306 | TRAC-FAP (X3XT24) h(ICOS-4-1BB-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT24 | Mouse | Homology arm-EF1a-scFv-ICOS-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0823-LX44 | Anti-hFAP (36) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | 36 | Adenoviral vectors | |||||
XS-0923-LX93 | Anti-hFAP (CD28-41BB-CD3ζ) CAR-duplex CTLA4 pCDCAR1 Vector | Human | X9X-62 | scFv-CD28-41BB-CD3ζ-duplex CTLA4 | Lentiviral vector | T cell | CAR-T |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION